oxymatrine has been researched along with astragaloside a in 2 studies
| Studies (oxymatrine) | Trials (oxymatrine) | Recent Studies (post-2010) (oxymatrine) | Studies (astragaloside a) | Trials (astragaloside a) | Recent Studies (post-2010) (astragaloside a) |
|---|---|---|---|---|---|
| 412 | 16 | 270 | 675 | 5 | 573 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, S; Kadowaki, M; Yamamoto, T; Zhang, Y | 1 |
| Che, X; Chen, Y; Liu, Y; Mao, D; Wang, H; Wei, L; Ye, X | 1 |
2 other study(ies) available for oxymatrine and astragaloside a
| Article | Year |
|---|---|
Suppression of plasmacytoid dendritic cell migration to colonic isolated lymphoid follicles abrogates the development of colitis.
Topics: Alkaloids; Animals; Cell Movement; Colitis; Colon; Dendritic Cells; Dextran Sulfate; Male; Mice; Mice, Inbred BALB C; Quinolizines; Saponins; Tertiary Lymphoid Structures; Triterpenes | 2021 |
Combination of oxymatrine (Om) and astragaloside IV (As) enhances the infiltration and function of TILs in triple-negative breast cancer (TNBC).
Topics: Animals; Cancer-Associated Fibroblasts; CD8-Positive T-Lymphocytes; Humans; Mice; Triple Negative Breast Neoplasms; Tumor Microenvironment | 2023 |